Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jul 23;203:741–766. doi: 10.1016/j.matcom.2022.07.012

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 International Association for Mathematics and Computers in Simulation (IMACS). Published by Elsevier B.V. All rights reserved.

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

PMC Copyright notice

Fig. 12 — (A) The local stability of $P_{0}$ of the omicron model (1) for $R_{0} < 1$ , (B) Global stability of disease free equilibrium shown in $S_{0} - I_{A} - I_{S}$ phase space for $R_{0} < 1$ , (C) Susceptible population without vaccination $(S_{0})$ against infected & asymptomatic population $(I_{A})$ over time ‘t’ for $R_{0} < 1$ , (D) Susceptible population without vaccination $(S_{0})$ against infected & symptomatic population $(I_{S})$ over time ‘t’ for $R_{0} < 1$ , (E) Susceptible population & vaccinated with dose-1 $(S_{1})$ against infected & asymptomatic population $(I_{A})$ over time ‘t’ for $R_{0} < 1$ , (F) Susceptible population & vaccinated with dose-2 $(S_{2})$ against infected & asymptomatic population $(I_{A})$ over time ‘t’ for $R_{0} < 1$ , (G) Susceptible population & vaccinated with dose-1 $(S_{1})$ against infected & symptomatic population $(I_{S})$ over time ‘t’ for $R_{0} < 1$ and (H) Susceptible population & vaccinated with dose-2 $(S_{2})$ against infected & symptomatic population $(I_{S})$ over time ‘t’ for $R_{0} < 1$ .